DMX Pharma Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,000

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 5

  • Investments
  • 3

DMX Pharma General Information

Description

Operator of technology-based contract development and manufacturing organization intended for branded and generic pharma companies. The company manufactures and packages solid pharmaceutical oral dosage forms, solid parenteral, high-activity solids, semi-solids and liquids and effervescent alimentary granules also offers probiotic-based nutritional supplements in powder and granules serving clients as per requirements.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Viale Bianca Maria 25
  • 20122 Milan
  • Italy
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Viale Bianca Maria 25
  • 20122 Milan
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DMX Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DMX Pharma‘s full profile, request access.

Request a free trial

DMX Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DMX Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DMX Pharma‘s full profile, request access.

Request a free trial

DMX Pharma Investments (3)

DMX Pharma’s most recent deal was a Buyout/LBO with Dietopack. The deal was made on 29-May-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dietopack 29-May-2020 Buyout/LBO BPO/Outsource Services
Ourvita 01-Jan-2003 Corporate BPO/Outsource Services
Pfizer (Milan Plant based in Rozzano, Italy) 01-Jan-2001 Corporate Asset Purchase Buildings and Property
To view DMX Pharma’s complete investments history, request access »

DMX Pharma Exits (1)

DMX Pharma’s most recent exit was on 29-May-2020 from Dietopack. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Dietopack 29-May-2020 Completed
  • 2 buyers
To view DMX Pharma’s complete exits history, request access »

DMX Pharma FAQs

  • When was DMX Pharma founded?

    DMX Pharma was founded in 1994.

  • Where is DMX Pharma headquartered?

    DMX Pharma is headquartered in Milan, Italy.

  • What is the size of DMX Pharma?

    DMX Pharma has 1,000 total employees.

  • What industry is DMX Pharma in?

    DMX Pharma’s primary industry is Pharmaceuticals.

  • Is DMX Pharma a private or public company?

    DMX Pharma is a Private company.

  • What is DMX Pharma’s current revenue?

    The current revenue for DMX Pharma is .

  • How much funding has DMX Pharma raised over time?

    DMX Pharma has raised $14.1M.

  • Who are DMX Pharma’s investors?

    Hoechst Roussel Pharmaceuticals and Trilantic Europe have invested in DMX Pharma.

  • When was DMX Pharma acquired?

    DMX Pharma was acquired on 07-Jan-2026.

  • Who acquired DMX Pharma?

    DMX Pharma was acquired by Mipharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process